Interleukin-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV

<strong>A. Gupta, E. Righi, A. Konnova, C. Sciammarella et al.</strong>

<strong>Contributing partner:</strong>
CINECA, Italy

<strong>Scientific article available at:</strong>
<a href=“https://doi.org/10.1002/pds.5857″ rel=“noopener“>“PDS“</a>